This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Sep 21;142(12):1032-1034.

doi: 10.1182/blood.2023021385.

New targeted therapy for hemophilia

Roger J S Preston¹

Affiliations

PMID: 37733378
DOI: 10.1182/blood.2023021385

Free article

Editorial

New targeted therapy for hemophilia

Roger J S Preston. Blood. 2023.

Free article

. 2023 Sep 21;142(12):1032-1034.

doi: 10.1182/blood.2023021385.

Author

Roger J S Preston¹

Affiliation

¹ Royal College of Surgeons in Ireland University of Medicine and Health Sciences and Children's Health Ireland Crumlin.

PMID: 37733378
DOI: 10.1182/blood.2023021385

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of an anti-human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models.
Jiang M, Yang F, Jiang Y, Cheng L, Han J, Yi J, Zuo B, Huang L, Ma Z, Li T, Cao LJ, Xia Z, Bai X, Jia C, Yang TTC, Esmon NL, Ruan C, Xia L, Esmon CT, Han Y, Wu D, Xu J. Jiang M, et al. Blood. 2023 Sep 21;142(12):1071-1081. doi: 10.1182/blood.2023020005. Blood. 2023. PMID: 37294924

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information